Aug. 24, 2011
GREENFORD, UK— online pharmacy semaglutide over the counter with best prices today in the USA Glaxo Group Limited (GSK) will take a £1,250,000 (about $2 million) equity stake in Autifony Therapeutics Ltd., a new British biotech company spun off from GSK. Under the agreement, announced on August 22, the British subsidiary of the global pharmaceutical giant GlaxoSmithKline, will own 25.4%






